Guilhem Richard

1.1k total citations
22 papers, 360 citations indexed

About

Guilhem Richard is a scholar working on Molecular Biology, Immunology and Oncology. According to data from OpenAlex, Guilhem Richard has authored 22 papers receiving a total of 360 indexed citations (citations by other indexed papers that have themselves been cited), including 11 papers in Molecular Biology, 10 papers in Immunology and 6 papers in Oncology. Recurrent topics in Guilhem Richard's work include Immunotherapy and Immune Responses (7 papers), vaccines and immunoinformatics approaches (6 papers) and Cancer Immunotherapy and Biomarkers (5 papers). Guilhem Richard is often cited by papers focused on Immunotherapy and Immune Responses (7 papers), vaccines and immunoinformatics approaches (6 papers) and Cancer Immunotherapy and Biomarkers (5 papers). Guilhem Richard collaborates with scholars based in United States, Italy and United Kingdom. Guilhem Richard's co-authors include Anne S. De Groot, William Martin, Leonard Moise, Gary D. Steinberg, Michael F. Princiotta, Klaas Vandepoele, Carolyn M. Nielsen, Simon J. Draper, Sofie Van Landeghem and Yves Van de Peer and has published in prestigious journals such as SHILAP Revista de lepidopterología, PLoS ONE and Cancer Research.

In The Last Decade

Guilhem Richard

20 papers receiving 355 citations

Peers

Guilhem Richard

IMMUN

RNMI

ONCOL

Anand Kumar India

Stine B. Clemmensen United Kingdom

Philip Hobson United Kingdom

Max Søgaard Denmark

Yusuke Sayama Japan

Jeffrey H. Ringrose Netherlands

Joanna Jasińska Austria

István Tombácz United States

Cheng Xiong China

Minako Masuda Japan

Anand Kumar India

Guilhem Richard

174 ×0.8

139 ×1.1

IMMUN

43 ×0.7

65 ×1.2

RNMI

34 ×0.7

ONCOL

Citations per year, relative to Guilhem Richard Guilhem Richard (= 1×) peers Anand Kumar

Countries citing papers authored by Guilhem Richard

Since Specialization

Citations

This map shows the geographic impact of Guilhem Richard's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Guilhem Richard with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Guilhem Richard more than expected).

Fields of papers citing papers by Guilhem Richard

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Guilhem Richard. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Guilhem Richard. The network helps show where Guilhem Richard may publish in the future.

Co-authorship network of co-authors of Guilhem Richard

This figure shows the co-authorship network connecting the top 25 collaborators of Guilhem Richard. A scholar is included among the top collaborators of Guilhem Richard based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Guilhem Richard. Guilhem Richard is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Kobayashi, Daiki, Queenie Lai Kwan Lam, Shigeharu Fujita, et al.. (2025). A method for identifying neoantigens through isolation of circulating tumor cells using apheresis among patients with advanced-stage cancer. Frontiers in Immunology. 16. 1609116–1609116.

Groot, Anne S. De, et al.. (2025). Immunogenicity of Generic Peptide Impurities: Current Orthogonal Approaches. Pharmaceutical Research. 42(5). 805–818.

Richard, Guilhem, et al.. (2024). Neoadjuvant personalized cancer vaccines: the final frontier?. Expert Review of Vaccines. 23(1). 205–212. 8 indexed citations

Sluder, Ann E., Susan Raju Paul, Leonard Moise, et al.. (2022). Evaluation of a Human T Cell-Targeted Multi-Epitope Vaccine for Q Fever in Animal Models of Coxiella burnetii Immunity. Frontiers in Immunology. 13. 901372–901372. 14 indexed citations

Richard, Guilhem, et al.. (2022). 100 Tumor homology with self as a biomarker for response to checkpoint inhibitor therapy. Regular and Young Investigator Award Abstracts. A110–A110. 1 indexed citations

Richard, Guilhem, Michael F. Princiotta, Dominique Bridon, et al.. (2021). Neoantigen-based personalized cancer vaccines: the emergence of precision cancer immunotherapy. Expert Review of Vaccines. 21(2). 173–184. 37 indexed citations

Richard, Guilhem, Anne S. De Groot, Gary D. Steinberg, et al.. (2021). Multi-step screening of neoantigens’ HLA- and TCR-interfaces improves prediction of survival. Scientific Reports. 11(1). 9983–9983. 6 indexed citations

Groot, Anne S. De, Leonard Moise, Frances Terry, et al.. (2020). Better Epitope Discovery, Precision Immune Engineering, and Accelerated Vaccine Design Using Immunoinformatics Tools. Frontiers in Immunology. 11. 442–442. 114 indexed citations

Kruiswijk, Corine P., Guilhem Richard, Merijn L.M. Salverda, et al.. (2020). In silicoidentification and modification of T cell epitopes in pertussis antigens associated with tolerance. Human Vaccines & Immunotherapeutics. 16(2). 277–285. 21 indexed citations

10.

Scholzen, Anja, Guilhem Richard, Leonard Moise, et al.. (2019). Coxiella burnetii Epitope-Specific T-Cell Responses in Patients with Chronic Q Fever. Infection and Immunity. 87(10). 11 indexed citations

11.

Hoffmann, Peter R., FuKun W. Hoffmann, Thomas A. Premeaux, et al.. (2019). Multi-antigen Vaccination With Simultaneous Engagement of the OX40 Receptor Delays Malignant Mesothelioma Growth and Increases Survival in Animal Models. Frontiers in Oncology. 9. 720–720. 8 indexed citations

12.

Scholzen, Anja, Guilhem Richard, Leonard Moise, et al.. (2019). Promiscuous Coxiella burnetii CD4 Epitope Clusters Associated With Human Recall Responses Are Candidates for a Novel T-Cell Targeted Multi-Epitope Q Fever Vaccine. Frontiers in Immunology. 10. 207–207. 34 indexed citations

13.

Groot, Anne S. De, Gail Skowron, James R. White, et al.. (2019). Therapeutic administration of Tregitope-Human Albumin Fusion with Insulin Peptides to promote Antigen-Specific Adaptive Tolerance Induction. Scientific Reports. 9(1). 22 indexed citations

14.

Richard, Guilhem, et al.. (2019). Abstract B089: Application of precision cancer immunotherapy design tools to bladder cancer: Non-self-like neoepitopes as a prognostic biomarker. Cancer Immunology Research. 7(2_Supplement). B089–B089. 1 indexed citations

15.

Vandepoele, Klaas, Michiel Van Bel, Guilhem Richard, et al.. (2013). pico‐ PLAZA , a genome database of microbial photosynthetic eukaryotes. Environmental Microbiology. 15(8). 2147–2153. 57 indexed citations

16.

Richard, Guilhem, Niraj Trivedi, Călin Belta, & Salomon Amar. (2013). Partial Restoration of Macrophage Alteration from Diet-Induced Obesity in Response to Porphyromonas gingivalis Infection. PLoS ONE. 8(7). e70320–e70320. 7 indexed citations

17.

Richard, Guilhem, A. Agung Julius, & Călin Belta. (2013). Optimizing regulation functions in gene network identification. 47. 745–750. 3 indexed citations

18.

Richard, Guilhem, Călin Belta, A. Agung Julius, & Salomon Amar. (2012). Controlling the Outcome of the Toll-Like Receptor Signaling Pathways. PLoS ONE. 7(2). e31341–e31341. 4 indexed citations

19.

Richard, Guilhem, et al.. (2011). Integration of large-scale metabolic, signaling, and gene regulatory networks with application to infection responses. 2227–2232. 7 indexed citations

20.

Richard, Guilhem, et al.. (2011). An application of monotone functions decomposition to the reconstruction of gene regulatory networks. PubMed. 36. 2430–2433. 2 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact